GE selling off biopharma business in $21.4B deal

Danaher's massive buy bolsters its life sciences unit. GE, meanwhile, plans to strengthen its balance sheet with the cash infusion and is reportedly pausing IPO plans for GE Healthcare.

By Andrew Dunn • Feb. 25, 2019

Boston Scientific-BTG deal faces FTC holdup

The embolization beads businesses are at the heart of U.S. anti-trust regulators' concerns.

By Maria Rachal • Feb. 15, 2019

HIMSS19: Digital health 'at peak investment cycle,' expert says

Last year's record level of investment into United States digital health companies came despite a lull in initial public offerings.

By David Lim • Feb. 14, 2019

Boston Scientific targets structural heart, international market growth in 2019

A near-constant stream of acquisitions defined the device giant's 2018. Now, it's looking ahead to product launches in the U.S., Europe and Japan.

By Maria Rachal • Feb. 6, 2019

Zimmer Biomet narrowly beats Q4 expectations, looks to Rosa knee soft launch

RBC Capital Markets analysts predicted the company's second half of 2019 is primed for faster growth once Rosa and other new knee product launches kick in.

By David Lim • Feb. 1, 2019

Many health startups, like Theranos, lack peer-reviewed data to back claims

Of 18 current healthcare "unicorns," 10 had no highly cited published medical papers and three had no published papers at all, according to Stanford researchers.

By Meg Bryant • Jan. 31, 2019

Medtronic buys Epix to boost cardiac ablation unit

Terms for the acquisition were not disclosed, but the device giant said the company is pre-revenue and the deal will be dilutive.

By David Lim • Jan. 25, 2019

As shutdown stalls IPOs, companies mull creative paths to market

Biotechs in the process of going public are considering legal workarounds to bypass a hamstrung SEC, but the Nasdaq appears to be proceeding warily.

By Andrew Dunn • Jan. 18, 2019

Abbott inks Cephea buyout to boost mitral valve pipeline

The takeover gives Abbott another valve replacement device to rival those owned by Edwards and Medtronic.

By Nick Paul Taylor • Jan. 17, 2019

LabCorp and Quest prepare for year of M&A as price cuts hit small labs

The laboratory testing giants expect reimbursement reductions to wipe out profits at smaller rivals, triggering a period of heavy consolidation.

By Nick Paul Taylor • Jan. 9, 2019

Wright Medical posts $9.5M in Cartiva revenue, beating expectations

The device maker's acquisition of Cartiva and its big toe arthritis implant boosted results. 

By David Lim • Jan. 7, 2019

Boston Scientific strikes $325M Millipede mitral valve repair buyout

The takeover gives Boston Scientific a foothold in a market predicted to grow to $1 billion by 2021.

By Nick Paul Taylor • Jan. 3, 2019

Regulatory makeovers and international game changers: MedTech Dive's top stories of 2018

Hard looks at cybersecurity and digital health's hot streak also left their mark on the year.

By Maria Rachal • Dec. 22, 2018

3M completes acquisition of MModal's tech business for $1B

The manufacturer plans to use MModal's cloud-based, conversational AI technology in areas like population health, where 3M is already active. 

By Meg Bryant • Updated Feb. 4, 2019

Medtronic launches spinal surgery system with Mazor technology

U.S. patients are now being treated with Medtronic's fully-integrated spinal surgery system, born from the 2018 buyout of Israel's Mazor Robotics.

By Maria Rachal • Updated Jan. 28, 2019

Smith & Nephew completes meniscus repair acquisition

The company said Tuesday its $50 million purchase of Ceterix Orthopaedics has closed, with additional payouts up to $55 million possible over the next five years based on the associated meniscal repair system's financial performance.

By Maria Rachal • Updated Jan. 23, 2019

Livongo names Cerner's Burke as new CEO

Current CEO Glen Tullman will take the title of executive chairman. Tullman told MedTech Dive in an interview before the move that revenue is set to more than double in 2018 to about $61 million.

By David Lim • Dec. 19, 2018

Allscripts to sell stake in Netsmart for $525M

The EHR vendor said the sale will allow it to pay back long-term debt and invest in other areas.

By Samantha Liss • Dec. 11, 2018

ResMed buys maker of COPD, asthma monitoring platform

The acquisition of Propeller follows a growing trend by device makers to acquire or partner with digital technology companies. 

By Susan Kelly • Dec. 5, 2018

The MedTech Dive Awards of 2018

The awards recognize the industry's top disruptors and newsmakers. These officials and companies are shaking up the medical technology sector and shaping the future.

By MedTech Dive Team • Dec. 3, 2018

CVS-Aetna megamerger finalized

The total value of the acquisition, including assumption of Aetna's debt, clocks in at $78 billion. The union creates the second biggest private company by revenue after Walmart.

By Rebecca Pifer • Nov. 28, 2018

Quest closes buy of Midwest lab services business

Completion of the deal for Columbia, Missouri-based Boyce and Bynum Pathology Laboratories comes as the lab services giant prepares to release financial results later this week.

By Susan Kelly • Updated Feb. 12, 2019

Boston Scientific snags BTG for $4.2B

The Federal Trade Commission cleared the merger and the deal is now slated to take effect Aug. 19, Boston Scientific said in an SEC filing Wednesday, a month after it addressed antitrust concerns by divesting its beads business.

By Nick Paul Taylor • Updated Aug. 7, 2019

Colfax strikes $3.15B buyout of orthopaedics player DJO

The acquisition will move the industrial technology conglomerate into a new market: medical devices.

By Nick Paul Taylor • Nov. 20, 2018

ResMed wraps up $750M MatrixCare buyout in SaaS push

The sleep apnea company has spent almost $1.7 billion on software businesses in recent years.

By Nick Paul Taylor • Nov. 15, 2018